222 related articles for article (PubMed ID: 29516675)
21. Pathology and biology associated with the fragile FHIT gene and gene product.
Saldivar JC; Shibata H; Huebner K
J Cell Biochem; 2010 Apr; 109(5):858-65. PubMed ID: 20082323
[TBL] [Abstract][Full Text] [Related]
22. Potential cancer therapy with the fragile histidine triad gene: review of the preclinical studies.
Ishii H; Dumon KR; Vecchione A; Fong LY; Baffa R; Huebner K; Croce CM
JAMA; 2001 Nov; 286(19):2441-9. PubMed ID: 11712940
[TBL] [Abstract][Full Text] [Related]
23. FHIT: doubts are clear now.
Wali A
ScientificWorldJournal; 2010 Jun; 10():1142-51. PubMed ID: 20563537
[TBL] [Abstract][Full Text] [Related]
24. Comparative genomic mapping of the bovine Fragile Histidine Triad (FHIT) tumour suppressor gene: characterization of a 2 Mb BAC contig covering the locus, complete annotation of the gene, analysis of cDNA and of physiological expression profiles.
Uboldi C; Guidi E; Roperto S; Russo V; Roperto F; Di Meo GP; Iannuzzi L; Floriot S; Boussaha M; Eggen A; Ferretti L
BMC Genomics; 2006 May; 7():123. PubMed ID: 16719907
[TBL] [Abstract][Full Text] [Related]
25. Loss of heterozygosity and microsatellite instabilities of fragile histidine triad gene in gastric carcinoma.
Xiao YP; Wu DY; Xu L; Xin Y
World J Gastroenterol; 2006 Jun; 12(23):3766-9. PubMed ID: 16773697
[TBL] [Abstract][Full Text] [Related]
26. Down-regulation of FHIT inhibits apoptosis of colorectal cancer: mechanism and clinical implication.
Cao J; Li W; Xie J; Du H; Tang W; Wang H; Chen X; Xiao W; Li Y
Surg Oncol; 2006 Dec; 15(4):223-33. PubMed ID: 17382535
[TBL] [Abstract][Full Text] [Related]
27. Analysis of the fragile histidine triad (FHIT) gene in lobular breast cancer.
Huiping C; Jonasson JG; Agnarsson BA; Sigbjornsdottir BI; Huebner K; Ingvarsson S
Eur J Cancer; 2000 Aug; 36(12):1552-7. PubMed ID: 10930803
[TBL] [Abstract][Full Text] [Related]
28. Promoter methylation status of the FHIT gene and Fhit expression: association with HER2/neu status in breast cancer patients.
Jeong YJ; Jeong HY; Lee SM; Bong JG; Park SH; Oh HK
Oncol Rep; 2013 Nov; 30(5):2270-8. PubMed ID: 23969757
[TBL] [Abstract][Full Text] [Related]
29. Fragile histidine triad (FHIT) gene is overexpressed in colorectal cancer.
Wierzbicki PM; Adrych K; Kartanowicz D; Dobrowolski S; Stanislawowski M; Chybicki J; Godlewski J; Korybalski B; Smoczynski M; Kmiec Z
J Physiol Pharmacol; 2009 Oct; 60 Suppl 4():63-70. PubMed ID: 20083853
[TBL] [Abstract][Full Text] [Related]
30. Loss of FHIT expression in breast cancer is correlated with poor prognostic markers.
Arun B; Kilic G; Yen C; Foster B; Yardley DA; Gaynor R; Ashfaq R
Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1681-5. PubMed ID: 16030101
[TBL] [Abstract][Full Text] [Related]
31. Alteration of the fragile histidine triad gene in intrahepatic cholangiocarcinoma.
Koch E; Fiedler W; Tannapfel A; Ballhausen WG
Eur J Gastroenterol Hepatol; 2003 Aug; 15(8):907-13. PubMed ID: 12867802
[TBL] [Abstract][Full Text] [Related]
32. Aberration of FHIT gene is associated with increased tumor proliferation and decreased apoptosis-clinical evidence in lung and head and neck carcinomas.
Pavelić K; Krizanac S; Cacev T; Hadzija MP; Radosević S; Crnić I; Levanat S; Kapitanović S
Mol Med; 2001 Jul; 7(7):442-53. PubMed ID: 11683369
[TBL] [Abstract][Full Text] [Related]
33. [FHIT--tumor suppressor protein involved in induction of apoptosis and cell cycle regulation].
Pecherzewska R; Nawrot B
Postepy Biochem; 2009; 55(1):66-75. PubMed ID: 19514467
[TBL] [Abstract][Full Text] [Related]
34. Identification of unstable sequences within the common fragile site at 3p14.2: implications for the mechanism of deletions within fragile histidine triad gene/common fragile site at 3p14.2 in tumors.
Corbin S; Neilly ME; Espinosa R; Davis EM; McKeithan TW; Le Beau MM
Cancer Res; 2002 Jun; 62(12):3477-84. PubMed ID: 12067991
[TBL] [Abstract][Full Text] [Related]
35. Frequent deletions of FHIT and FRA3B in Barrett's metaplasia and esophageal adenocarcinomas.
Michael D; Beer DG; Wilke CW; Miller DE; Glover TW
Oncogene; 1997 Oct; 15(14):1653-9. PubMed ID: 9349498
[TBL] [Abstract][Full Text] [Related]
36. Initiation of genome instability and preneoplastic processes through loss of Fhit expression.
Saldivar JC; Miuma S; Bene J; Hosseini SA; Shibata H; Sun J; Wheeler LJ; Mathews CK; Huebner K
PLoS Genet; 2012; 8(11):e1003077. PubMed ID: 23209436
[TBL] [Abstract][Full Text] [Related]
37. FHIT loss-induced DNA damage creates optimal APOBEC substrates: Insights into APOBEC-mediated mutagenesis.
Waters CE; Saldivar JC; Amin ZA; Schrock MS; Huebner K
Oncotarget; 2015 Feb; 6(5):3409-19. PubMed ID: 25401976
[TBL] [Abstract][Full Text] [Related]
38. Roles of FHIT and WWOX fragile genes in cancer.
Iliopoulos D; Guler G; Han SY; Druck T; Ottey M; McCorkell KA; Huebner K
Cancer Lett; 2006 Jan; 232(1):27-36. PubMed ID: 16225988
[TBL] [Abstract][Full Text] [Related]
39. The FHIT gene product: tumor suppressor and genome "caretaker".
Waters CE; Saldivar JC; Hosseini SA; Huebner K
Cell Mol Life Sci; 2014 Dec; 71(23):4577-87. PubMed ID: 25283145
[TBL] [Abstract][Full Text] [Related]
40. Reduced acetylated histone H4 is associated with promoter methylation of the fragile histidine triad gene in resected esophageal squamous cell carcinoma.
Tzao C; Sun GH; Tung HJ; Hsu HS; Hsu WH; Wang YC; Cheng YL; Lee SC
Ann Thorac Surg; 2006 Aug; 82(2):396-401; discussion 401. PubMed ID: 16863736
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
